Investigate Low Doses of Direct Oral Anticoagulants

More patients will be admitted on LOW-dose direct oral anticoagulants (DOACs) to prevent recurrent venous thromboembolism (VTE).

Most patients who have a VTE due to a short-term risk...such as surgery or minor trauma...will use warfarin or a DOAC (apixaban, etc) for just 3 months.

Long-term anticoagulation is needed for most patients at high risk of recurrence...such as those with active cancer or a clotting disorder.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals